AT8B1_HUMAN - dbPTM
AT8B1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AT8B1_HUMAN
UniProt AC O43520
Protein Name Phospholipid-transporting ATPase IC
Gene Name ATP8B1
Organism Homo sapiens (Human).
Sequence Length 1251
Subcellular Localization Cell membrane
Multi-pass membrane protein. Apical cell membrane . Cell projection, stereocilium . Endoplasmic reticulum . Golgi apparatus . Exit from the endoplasmic reticulum requires the presence of TMEM30A or TMEM30B (PubMed:20947505). Localizes
Protein Description Catalytic component of a P4-ATPase flippase complex which catalyzes the hydrolysis of ATP coupled to the transport of aminophospholipids from the outer to the inner leaflet of various membranes and ensures the maintenance of asymmetric distribution of phospholipids. Phospholipid translocation seems also to be implicated in vesicle formation and in uptake of lipid signaling molecules. May play a role in asymmetric distribution of phospholipids in the canicular membrane. May have a role in transport of bile acids into the canaliculus, uptake of bile acids from intestinal contents into intestinal mucosa or both. In cooperation with ABCB4 may be involved in establishing integrity of the canalicular membrane thus protecting hepatocytes from bile salts. Together with TMEM30A is involved in uptake of the synthetic drug alkylphospholipid perifosine. Involved in the microvillus formation in polarized epithelial cells; the function seems to be independent from its flippase activity. Required for the preservation of cochlear hair cells in the inner ear. May act as cardiolipin transporter during inflammatory injury..
Protein Sequence MSTERDSETTFDEDSQPNDEVVPYSDDETEDELDDQGSAVEPEQNRVNREAEENREPFRKECTWQVKANDRKYHEQPHFMNTKFLCIKESKYANNAIKTYKYNAFTFIPMNLFEQFKRAANLYFLALLILQAVPQISTLAWYTTLVPLLVVLGVTAIKDLVDDVARHKMDKEINNRTCEVIKDGRFKVAKWKEIQVGDVIRLKKNDFVPADILLLSSSEPNSLCYVETAELDGETNLKFKMSLEITDQYLQREDTLATFDGFIECEEPNNRLDKFTGTLFWRNTSFPLDADKILLRGCVIRNTDFCHGLVIFAGADTKIMKNSGKTRFKRTKIDYLMNYMVYTIFVVLILLSAGLAIGHAYWEAQVGNSSWYLYDGEDDTPSYRGFLIFWGYIIVLNTMVPISLYVSVEVIRLGQSHFINWDLQMYYAEKDTPAKARTTTLNEQLGQIHYIFSDKTGTLTQNIMTFKKCCINGQIYGDHRDASQHNHNKIEQVDFSWNTYADGKLAFYDHYLIEQIQSGKEPEVRQFFFLLAVCHTVMVDRTDGQLNYQAASPDEGALVNAARNFGFAFLARTQNTITISELGTERTYNVLAILDFNSDRKRMSIIVRTPEGNIKLYCKGADTVIYERLHRMNPTKQETQDALDIFANETLRTLCLCYKEIEEKEFTEWNKKFMAASVASTNRDEALDKVYEEIEKDLILLGATAIEDKLQDGVPETISKLAKADIKIWVLTGDKKETAENIGFACELLTEDTTICYGEDINSLLHARMENQRNRGGVYAKFAPPVQESFFPPGGNRALIITGSWLNEILLEKKTKRNKILKLKFPRTEEERRMRTQSKRRLEAKKEQRQKNFVDLACECSAVICCRVTPKQKAMVVDLVKRYKKAITLAIGDGANDVNMIKTAHIGVGISGQEGMQAVMSSDYSFAQFRYLQRLLLVHGRWSYIRMCKFLRYFFYKNFAFTLVHFWYSFFNGYSAQTAYEDWFITLYNVLYTSLPVLLMGLLDQDVSDKLSLRFPGLYIVGQRDLLFNYKRFFVSLLHGVLTSMILFFIPLGAYLQTVGQDGEAPSDYQSFAVTIASALVITVNFQIGLDTSYWTFVNAFSIFGSIALYFGIMFDFHSAGIHVLFPSAFQFTGTASNALRQPYIWLTIILAVAVCLLPVVAIRFLSMTIWPSESDKIQKHRKRLKAEEQWQRRQQVFRRGVSTRRSAYAFSHQRGYADLISSGRSIRKKRSPLDAIVADGTAEYRRTGDS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
15PhosphorylationETTFDEDSQPNDEVV
CCCCCCCCCCCCCCC
45.5528348404
24PhosphorylationPNDEVVPYSDDETED
CCCCCCCCCCCCCCC
17.0828348404
25PhosphorylationNDEVVPYSDDETEDE
CCCCCCCCCCCCCCC
32.3029802988
29PhosphorylationVPYSDDETEDELDDQ
CCCCCCCCCCCCCCC
56.5929802988
38PhosphorylationDELDDQGSAVEPEQN
CCCCCCCCCCCHHHH
24.4128348404
60MethylationENREPFRKECTWQVK
HHCCCCHHHCCEEEE
58.4823644510
417UbiquitinationVIRLGQSHFINWDLQ
EEECCCCEEECCEEE
21.5122817900
438PhosphorylationDTPAKARTTTLNEQL
CCCCCCCCCCHHHHH
29.0629759185
439PhosphorylationTPAKARTTTLNEQLG
CCCCCCCCCHHHHHC
24.5929759185
440PhosphorylationPAKARTTTLNEQLGQ
CCCCCCCCHHHHHCC
27.2929759185
455UbiquitinationIHYIFSDKTGTLTQN
EEEEEECCCCCEECC
47.8922817900
476PhosphorylationCCINGQIYGDHRDAS
HEECCEECCCCCCCH
14.49-
584PhosphorylationITISELGTERTYNVL
EEEECCCCCCEEEEE
34.6124719451
609PhosphorylationRMSIIVRTPEGNIKL
EEEEEEECCCCCEEE
18.1329396449
615MethylationRTPEGNIKLYCKGAD
ECCCCCEEEEECCCC
37.09-
639UbiquitinationMNPTKQETQDALDIF
CCCCCCHHHHHHHHH
29.2929901268
658PhosphorylationLRTLCLCYKEIEEKE
HHHHHHHHHHHHHHH
9.94-
667PhosphorylationEIEEKEFTEWNKKFM
HHHHHHCHHHHHHHH
40.9824719451
689UbiquitinationNRDEALDKVYEEIEK
CHHHHHHHHHHHHHH
47.7929901268
779PhosphorylationQRNRGGVYAKFAPPV
CCCCCCCCCCCCCCC
13.83-
789PhosphorylationFAPPVQESFFPPGGN
CCCCCCCCCCCCCCC
18.33-
902AcetylationANDVNMIKTAHIGVG
CCCCCEEEEEEEECC
28.9619825509
924PhosphorylationQAVMSSDYSFAQFRY
HHHHCCCCCHHHHHH
13.98-
925PhosphorylationAVMSSDYSFAQFRYL
HHHCCCCCHHHHHHH
21.06-
931PhosphorylationYSFAQFRYLQRLLLV
CCHHHHHHHHHHHHH
14.4226074081
992PhosphorylationITLYNVLYTSLPVLL
HHHHHHHHHHHHHHH
7.04-
1012PhosphorylationQDVSDKLSLRFPGLY
CCCCHHHCCCCCCEE
24.2024719451
1173PhosphorylationLSMTIWPSESDKIQK
HHCCCCCCCHHHHHH
34.4329759185
1175PhosphorylationMTIWPSESDKIQKHR
CCCCCCCHHHHHHHH
48.8429759185
1203PhosphorylationQVFRRGVSTRRSAYA
HHHHHCCCHHHHHHH
21.0124719451
1204PhosphorylationVFRRGVSTRRSAYAF
HHHHCCCHHHHHHHH
27.91-
1207PhosphorylationRGVSTRRSAYAFSHQ
HCCCHHHHHHHHCCC
23.4925849741
1209PhosphorylationVSTRRSAYAFSHQRG
CCHHHHHHHHCCCCC
14.9323911959
1212PhosphorylationRRSAYAFSHQRGYAD
HHHHHHHCCCCCHHH
15.5629038488
1217PhosphorylationAFSHQRGYADLISSG
HHCCCCCHHHHHHCC
10.1127273156
1222PhosphorylationRGYADLISSGRSIRK
CCHHHHHHCCCCCCC
33.7525849741
1223PhosphorylationGYADLISSGRSIRKK
CHHHHHHCCCCCCCC
31.0926356563
1226PhosphorylationDLISSGRSIRKKRSP
HHHHCCCCCCCCCCC
30.2123312004
1232PhosphorylationRSIRKKRSPLDAIVA
CCCCCCCCCCHHEEE
38.4023312004
1242PhosphorylationDAIVADGTAEYRRTG
HHEEECCCHHHHCCC
19.50-
1245PhosphorylationVADGTAEYRRTGDS-
EECCCHHHHCCCCC-
11.7027259358

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of AT8B1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of AT8B1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AT8B1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CC50A_HUMANTMEM30Aphysical
21914794
CC50B_HUMANTMEM30Bphysical
21914794

Drug and Disease Associations
Kegg Disease
H00624 Familial cholestasis, including: Progressive familial intrahepatic cholestasis (PFIC); Benign recurr
OMIM Disease
211600Cholestasis, progressive familial intrahepatic, 1 (PFIC1)
243300Cholestasis, benign recurrent intrahepatic, 1 (BRIC1)
147480Cholestasis of pregnancy, intrahepatic 1 (ICP1)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of AT8B1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1217, AND MASSSPECTROMETRY.

TOP